Neural Regeneration Research ›› 2023, Vol. 18 ›› Issue (12): 2680-2681.doi: 10.4103/1673-5374.371360

Previous Articles     Next Articles

TREM2 as an evolving therapeutic target in Alzheimer’s disease

Jacob George*   

  1. Cognyxx Pharmaceuticals, Tel Aviv Israel and Kaplan Heart Center, Rehovot, Israel
  • Online:2023-12-15 Published:2023-06-15
  • Contact: Jacob George, MD, Kobi@cognyxx.com.

PDF

41